EUVIMEDEUVIMED entdecken
Crossref

Microglial Membrane‐Coated Biomimetic Nanoplatform for Enhanced Blood–Brain Barrier Penetration and Targeted Photodynamic Therapy in Orthotopic Glioblastoma

Jie Li, Xiaoyu Xu, Yuhang Zhao, Xuan Wu, Siyu Chen, Jiange Xu, Rong Xiao, Jing Tang, Xuechuan Hong, Shi Chen, Zhiqiang Li, Meijia Gu iD

Advanced Healthcare Materials · 2026-01 · 15 (1)

DOI: 10.1002/adhm.202502808 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 04.09.2025. Verfasst von Jie Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Brain Center, Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Ministry of Education Key Laboratory of Combinatorial Biosynthesis a…. Hauptthemen laut MEDLINE: Glioblastoma, Photochemotherapy, Blood-Brain Barrier, Microglia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Key Research and Development Program Project of Hubei Province, Shenzhen Science and Technology Program, Key Technologies Research and Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma multiforme (GBM) continues to pose a significant challenge in the field of neuro‐oncology primarily because of the limited penetration of therapeutics across the blood‐brain barrier (BBB) and the presence of immunosuppressive tumor microenvironments. To address these challenges, a HD‐PEG 2K @BM biomimetic nanoplatform (hereinafter referred to as HD‐P@BM) is developed that cloaks the near‐infrared II photosensitizer HD‐PEG 2K (HD‐P) inside microglial membranes to enable enhanced BBB penetration and tumor‐targeted delivery. In this study, it is found that the microglia‐derived membranes enhanced the uptake of nanoparticles by both the glioma cells and tumor‐associated microglia. Furthermore, irradiation with 808 nm laser induced a photodynamic effect that caused mitochondrial dysfunction and elicited immunogenic cell death. Notably, HD‐P@BM reprogrammed the immunosuppressive microglia to pro‐inflammatory M1 phenotypes, which promoted cytotoxic T‐cell infiltration and remodeled the tumor immune landscape. In orthotopic GBM models, HD‐P@BM significantly suppressed tumor growth, prolonged survival, and mitigated systemic toxicity. This multifunctional strategy synergized biomimetic delivery, photodynamic therapy (PDT), and immunotherapy is a promising therapeutic approach for GBM. Thus, this study establishes a multifunctional nanotherapeutic strategy that combines enhanced BBB penetration, precise tumor targeting, and synergistic PDT, showing high potential for effective clinical GBM treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaPhotochemotherapyBlood-Brain BarrierMicrogliaBiomimetic MaterialsNanoparticlesBrain NeoplasmsAnimalsMiceHumansCell Line, TumorPhotosensitizing Agents

Stichwörter der Autor:innen

HD‐P@BMbiomimetic nanoplatformblood−brain barrierglioblastoma multiformephotodynamic therapy

Substanzen

Photosensitizing Agents

Autor:innen und Institutionen

  • Brain Center, Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Ministry of Education Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, School of Pharmaceutical Sciences, Wuhan University…
  • Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430070, China.
  • Hubei International Science and Technology Cooperation Base for Research and Clinical Techniques for Brain Glioma Diagnosis and Treatment, Wuhan University, Wuhan, Hubei, 430071, China.
  • Wuhan Asia General Hospital, Wuhan, Hubei, 430070, China.
  • Department of Burn and Plastic Surgery, Shenzhen Key Laboratory of Microbiology in Genomic Modification & Editing and Application, Guangdong Provincial Key Laboratory of Systems Biology and Synthetic Biology for Urogeni…

ORCID-Profile: Meijia Gu

Förderung

  • Key Research and Development Program Project of Hubei Province
  • Shenzhen Science and Technology Program
  • Key Technologies Research and Development Program
  • Shenzhen Science and Technology Innovation Program

Zitieren

APA

Li, J., Xu, X., Zhao, Y., Wu, X., Chen, S., Xu, J., Xiao, R., Tang, J., Hong, X., Chen, S., Li, Z., & Gu, M. (2026). Microglial Membrane‐Coated Biomimetic Nanoplatform for Enhanced Blood–Brain Barrier Penetration and Targeted Photodynamic Therapy in Orthotopic Glioblastoma. Advanced Healthcare Materials, 15(1). https://doi.org/10.1002/adhm.202502808

Vancouver

Li J, Xu X, Zhao Y, Wu X, Chen S, Xu J, et al. Microglial Membrane‐Coated Biomimetic Nanoplatform for Enhanced Blood–Brain Barrier Penetration and Targeted Photodynamic Therapy in Orthotopic Glioblastoma. Advanced Healthcare Materials. 2026;15(1). doi:10.1002/adhm.202502808

BibTeX
@article{Li2026,
  author = {Li, Jie and Xu, Xiaoyu and Zhao, Yuhang and Wu, Xuan and Chen, Siyu and Xu, Jiange and Xiao, Rong and Tang, Jing and Hong, Xuechuan and Chen, Shi and Li, Zhiqiang and Gu, Meijia},
  title = {Microglial Membrane‐Coated Biomimetic Nanoplatform for Enhanced Blood–Brain Barrier Penetration and Targeted Photodynamic Therapy in Orthotopic Glioblastoma},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  volume = {15},
  number = {1},
  doi = {10.1002/adhm.202502808}
}
Kostenlos starten →